AI can transform healthcare, but risks remain: liability, bias, blurred “wellness vs medicine,” and jagged model errors.

THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...

This article is authored by Tushar Gupta, COO, Jubilant Biosys Limited (CRDMO).

The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.

From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

HEFEI CITY, ANHUI PROVINCE, CHINA, February 12, 2026 /EINPresswire.com/ -- The global temperature sensing industry has ...

Researchers have uncovered the enzyme behind chromothripsis, a chaotic chromosome-shattering event seen in about one in four ...